Philips Introduces ECG for Decentralized Trials


New solution looks to improve recruitment, compliance, and retention.

Royal Philips has announced the introduction of an at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution pairs data readings comparable to clinical, site-based ECGs with Philips cloud-based data collection and analysis services.

Leveraging PCA 500 ECG patch data recording technology, the at-home solution allows clinical trial participants to record data with quality comparable to site-based ECGs at home. The solution’s body-worn patch ensures compliant 12-lead ECG placement and near real-time, highly secure data transmission without the need for recurring site visits, onsite technician, or home nurses.

Read more about the new solution here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.